PPT-Overview of the NIH Guidelines

and Virginia Tech Institutional Biosafety Committee IBC VT IBC Institutional Biosafety Committee The Institutional Biosafety Committee IBC is involved in the establishment of biosafety policies that are used by Virginia Tech instructional and experimental research personnel to safely conduct activities involving recombinant and synthetic nucleic acid molecules genetically modified microorganisms plants and animals artificial gene transfer infectious agents and biologically derived toxins. . 1993-2011. Staff: something that upholds or sustains; the personnel responsible for the . functioning. of an institution . (Webster’s Third International Dictionary). History of Staff Scientists at the NIH. MDF Conference: 9/12/2014. John D. Porter, Ph.D.. Program Director. National Institute of Neurological Disorders and Stroke. National Institutes of Health. porterjo@ninds.nih.gov. . With thanks to Steve Korn & Glen Nuckolls. Undiagnosed Disease Program (UDP). September 10, . 2015. CAPT Michele Nehrebecky, MS, CRNP. Program Announcement . May 2008. Began with 2 Nurse Practitioners (both PHS) and 1 scheduler. Initial funding was $280,000. Patricia Valdez, Ph.D.. NIH Extramural Research Integrity Officer. OD/OER/OEP. National Institutes of Health. NIH OER Regionals, 2015. 2. Overview. Research Misconduct Allegations – . How NIH works with ORI. Judy Auerbach. ARI Faculty Meeting. October 21, 2015. Established in 1988 by Assistant Secretary of Health, Dr. Robert Windom, to coordinate trans-NIH AIDS research. Legislatively established in the Health Omnibus Programs Extension Act (HOPE) 1988 (P.L. 100-607). 1. Kim . M. . Gans. , PhD, MPH, LDN. Professor, Dept. of Behavioral & Social Sciences and . Director. , Institute for Community Health . Promotion . Brown . University School of Public Health. Who am I?. 2015 NIH Regional Seminar on Program Funding and Grants Administration . May 2015. Presented By:. Ann M. Hammersla, J.D., Director & Policy Officer. Division of Extramural Inventions & Technology Resources (DEITR),. september. 22, . 2017. Patricia Valdez, . p. h. d. Nih. extramural research integrity officer. 2. Nature. , 25 May 2016. The Reproducibility Challenge. Noted by research community; in multiple publications. Post-Submission. October 2018. electronic Research Administration (eRA). OER, OD, National Institutes of Health . Your Workshop Team. Scarlett Gibb. eRA Customer Relationship Manager, eRA . Commons. Joe . September 2017. Background. Recombinant DNA work is covered under NIH Office of Biotechnology Activities (NIH OBA) in:. NIH . GUIDELINES FOR RESEARCH . INVOLVING RECOMBINANT . OR SYNTHETIC NUCLEIC . ACID MOLECULES (April 2016). Synthetic . Nucleic Acid Molecules . (NIH Guidelines). Northern Arizona University. Office of Regulatory Compliance. Shelley Jones, Director of Biological Safety. Shelley.Jones@nau.edu. 928-523-7268. 2. On September 30, 2021, President Biden signed the Extending Government Funding and Delivering Emergency Assistance Act (Public Law 117-43). . NIH remains funded under a Continuing Resolution (CR) through December 3. November 4, 2021. Data & Resource Sharing:. Firming Foundations. For Future Frontiers. Julia Slutsman. , PhD. Director, Genomic Data Sharing Implementation. julia.slutsman@nih.gov. J.P. Kim. , JD, MBA, MSc, MPP, MA. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/biotechnology/nih-guidelines/. Evolving, scientifically-responsive document.